Impact of Type II LRRK2 inhibitors on signaling and mitophagy
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical Journal"
DOI: 10.1042/bcj20210375
Abstract: Much effort has been devoted to the development of selective inhibitors of the LRRK2 as a potential treatment for LRRK2 driven Parkinson's disease. In this study, we first compare the properties of Type I (GSK3357679A… read more here.
Keywords: type lrrk2; impact type; type inhibitors; lrrk2 inhibitors ... See more keywords